XTNT Xtant Medical Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: XTNT

Price (delayed)

$0.4615

Market cap

$64.73M

P/E Ratio

23.08

Dividend/share

N/A

EPS

$0.02

Enterprise value

$68.01M

?
Relative Growth: Rel. Growth: 37
Relative Strength: Rel. Strength: 14
Relative Valuation: Rel. Valuation: 91
Relative Profitability: Rel. Profitability: 66

Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal ...

Highlights
Xtant Medical Holdings's quick ratio has soared by 59% YoY
XTNT's debt has dropped by 55% year-on-year and by 46% since the previous quarter
The company's EPS has surged by 122% YoY but it has shrunk by 50% QoQ
XTNT's net income has soared by 115% year-on-year but it has dropped by 63% since the previous quarter
The revenue is down by 9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://xtantmedical.com
Peers: STE SYK

Key stats

What are the main financial stats of XTNT

XTNT stock price

How has the Xtant Medical Holdings stock price performed over time
Intraday
0.3%
1 week
-1.81%
1 month
-17.59%
1 year
-32.33%
YTD
-41.14%
QTD
-17.29%

Financial performance

How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$121.91M
Gross profit
$76M
Operating income
$3.3M
Net income
$1.83M
Gross margin
62.3%
Net margin
1.5%
Xtant Medical Holdings's operating margin has soared by 144% YoY but it has plunged by 50% from the previous quarter
XTNT's operating income has surged by 144% year-on-year but it has dropped by 55% since the previous quarter
XTNT's net income has soared by 115% year-on-year but it has dropped by 63% since the previous quarter
XTNT's net margin has surged by 115% year-on-year but it has dropped by 59% since the previous quarter

Price vs fundamentals

How does XTNT's price correlate with its fundamentals

Growth

What is Xtant Medical Holdings's growth rate over time

Valuation

What is Xtant Medical Holdings stock price valuation
XTNT P/E details
P/E
23.08
P/B
1.33
P/S
0.53
EV/EBIT
9.54
EV/EBITDA
5.76
EV/Sales
0.56
The company's EPS has surged by 122% YoY but it has shrunk by 50% QoQ
XTNT's P/B is 40% below its 5-year quarterly average of 2.2 and 30% below its last 4 quarters average of 1.9
The equity has grown by 11% YoY but it has contracted by 4.6% from the previous quarter
The stock's price to sales (P/S) is 52% less than its 5-year quarterly average of 1.1 and 24% less than its last 4 quarters average of 0.7
The revenue is down by 9% since the previous quarter

Efficiency

How efficient is Xtant Medical Holdings business performance
The company's return on sales has surged by 194% YoY but it fell by 28% QoQ
Xtant Medical Holdings's ROA has soared by 115% YoY but it has plunged by 62% from the previous quarter
The ROE has soared by 114% YoY but it has plunged by 64% from the previous quarter
Xtant Medical Holdings's ROIC has decreased by 27% from the previous quarter

Dividends

What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XTNT.

Financial health

How did Xtant Medical Holdings financials performed over time
The total assets is 165% more than the total liabilities
Xtant Medical Holdings's quick ratio has soared by 59% YoY
Xtant Medical Holdings's total liabilities has decreased by 43% YoY and by 32% from the previous quarter
XTNT's debt is 68% smaller than its equity
The debt to equity has plunged by 59% YoY and by 43% from the previous quarter
XTNT's debt has dropped by 55% year-on-year and by 46% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.